Stepwise low-pressure VAC for deep sternal infection in a 2.8-kg infant

Sanketh Edem1, Sachin Mahajan1, Jigyasa Bharti1

  • 1Department of Cardiothoracic and Vascular Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Low-pressure vacuum-assisted closure (VAC) effectively treated deep sternal wound infection in a ventilated infant. This method proved safe and aided recovery for critically ill neonates with unstable chest walls.

Area of Science:

  • Pediatric Surgery
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Deep sternal wound infection (DSWI) is a rare but serious complication following cardiac surgery in infants.
  • Ventilated infants with unstable chest walls pose unique challenges for wound management due to risks associated with high negative pressures.

Purpose of the Study:

  • To evaluate the safety and efficacy of low-pressure vacuum-assisted closure (VAC) for DSWI in a mechanically ventilated, very-low-weight infant.
  • To demonstrate an alternative wound management strategy for complex pediatric surgical site infections.

Main Methods:

  • A 2-month-old infant with DSWI post-cardiac repair was treated with polyurethane-foam VAC.
  • Therapy was initiated at low negative pressure (-40 mmHg), gradually increased to -50 mmHg, with dressings changed every third day.
  • Debridement was performed prior to VAC application.

Main Results:

  • The VAC therapy promoted progressive wound granulation over 12 days.
  • The deep sternal wound healed successfully by secondary intention.
  • The infant was extubated, recovered well, and was discharged on postoperative day 42.

Conclusions:

  • Stepwise low-pressure VAC is a safe and effective treatment for DSWI in ventilated, very-low-weight infants.
  • This approach mitigates risks associated with conventional high negative pressures in fragile patients.
  • VAC therapy offers a viable solution for complex pediatric wound management.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...